This is a test
- 200 pages
- English
- PDF
- Available on iOS & Android
eBook - PDF
Book details
Book preview
Table of contents
Citations
About This Book
Nucleosides exhibit a broad spectrum of biological activity that generally results from their ability to inhibit specific enzymes. This activity has led to their use in the development of various pharmaceutical agents used in the treatment of cancers and to combat harmful viruses, bacteria and parasites.Nucleoside Mimetics provides an intro
Frequently asked questions
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Both plans give you full access to the library and all of Perlego’s features. The only differences are the price and subscription period: With the annual plan you’ll save around 30% compared to 12 months on the monthly plan.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes, you can access Nucleoside Mimetics by Claire Simons in PDF and/or ePUB format, as well as other popular books in Medicine & Biochemistry in Medicine. We have over one million books available in our catalogue for you to explore.
Information
I
N
T
R
O
D
U
C
T
I
O
N
Ara-A
(Antiviral)
Nucleocidin
(Antitrypanosomal)
Toyocamycin
(Antitumour)
FUDR
(Anticancer)
8-Azainosine
(Anticancer)
Ara-C
(Antileukemia)
structure
and
mechanisms
of
antiviral/anticancer
activity
. 12" 16
O
f
particular
interest
was
the
discovery
of
activity
in
L-nucleosides
(such
as
3TC™),
the
unnatural
nucleoside
enantiomers,
and
the
non-nucleoside
reverse
transcriptase
inhibitors
(NNRTFs)
TSAO-T
and
HEPT
(see
section
1
.
7
.
1
.
2
)
Although
there
has
been
great
interest
in
the
reverse
transcriptase
inhibitors,
there
are
many
other
known
and
potential
enzymatic
targets,
including
both
cellular
enzymes
and
virus-specified
enzymes,
with
which
nucleoside
mimetics
can
interact
as
substrates/competitive
inhibitors
.17
Antiviral
specificity
is
often
required
for
mini
mum
toxicity,
however
the
more
specific
inhibitors
are
often
the
most
prone
to
the
formation
of
virus-drug
resistant
strains.
Therefore
a
balance
is
often
required
between
drug
specificity
and
toxicity
in
order
to
minimise
the
problem
of
drug
resistance.
1.2
STRUCTURE
OF
NUCLEOSIDES
The
nucleoside
components
of
RNA
and
DNA
are
composed
of
a
sugar
moiety,
ribose
(1.1,
p-D-riboftiranose)
and
2-deoxyribose
(1.2,
2-deoxy-p-D-ribofuranose)
2
N
U
C
L
E
O
S
I
D
E
M
I
ME
T
I
CS
Table of contents
- Cover
- Half Title
- Title Page
- Copyright Page
- Contents
- Preface
- Chapter 1 Introduction
- Chapter 2 Synthesis of Conventional D-Nucleosides
- Chapter 3 Sugar Modified Nucleosides
- Chapter 4 Heterocyclic Base Modified Nucleosides
- Chapter 5 L-Nudeosides
- Chapter 6 C-Nucleosides
- Chapter 7 Carbocyclic Nucleosides
- Chapter 8 Acyclic Nucleosides
- Index